Precision medicine for breast cancer: multi-omics towards predicting complete remission and avoiding surgery
Dauer: 48 Monate, Fördersumme: € 899.630
Validation of a liquid biopsy based molecular diagnostic toolkit for pediatric sarcomas
Dauer: 48 Monate, Fördersumme: € 899.160